ATE386053T1 - Verfahren zur isolierung eines intestilanen cholesterin bindenproteins - Google Patents

Verfahren zur isolierung eines intestilanen cholesterin bindenproteins

Info

Publication number
ATE386053T1
ATE386053T1 AT03784089T AT03784089T ATE386053T1 AT E386053 T1 ATE386053 T1 AT E386053T1 AT 03784089 T AT03784089 T AT 03784089T AT 03784089 T AT03784089 T AT 03784089T AT E386053 T1 ATE386053 T1 AT E386053T1
Authority
AT
Austria
Prior art keywords
intestilane
isolation
binding protein
cholesterol binding
cholesterol
Prior art date
Application number
AT03784089T
Other languages
English (en)
Inventor
Werner Kramer
Wendelin Frick
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE386053T1 publication Critical patent/ATE386053T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03784089T 2002-08-06 2003-07-28 Verfahren zur isolierung eines intestilanen cholesterin bindenproteins ATE386053T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02017504 2002-08-06

Publications (1)

Publication Number Publication Date
ATE386053T1 true ATE386053T1 (de) 2008-03-15

Family

ID=31502689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784089T ATE386053T1 (de) 2002-08-06 2003-07-28 Verfahren zur isolierung eines intestilanen cholesterin bindenproteins

Country Status (17)

Country Link
US (2) US7435727B2 (de)
EP (1) EP1529061B1 (de)
JP (1) JP4575772B2 (de)
KR (1) KR101095288B1 (de)
CN (1) CN1330667C (de)
AT (1) ATE386053T1 (de)
AU (1) AU2003253341C1 (de)
BR (1) BR0313217A (de)
CA (1) CA2493487C (de)
DE (1) DE60319093T2 (de)
HK (1) HK1082509A1 (de)
IL (2) IL166492A (de)
MX (1) MXPA05001264A (de)
NO (2) NO333437B1 (de)
RU (1) RU2345089C2 (de)
WO (1) WO2004014947A1 (de)
ZA (1) ZA200500053B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
DE602004029715D1 (de) 2003-12-23 2010-12-02 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
JP4590417B2 (ja) 2004-01-16 2010-12-01 メルク・シャープ・エンド・ドーム・コーポレイション Ｎｐｃ１ｌ１（ｎｐｃ３）およびこのリガンドの同定方法
JP2008546784A (ja) 2005-06-20 2008-12-25 シェーリング コーポレイション ヒスタミンｈ３アンタゴニストとして有用なピペリジン誘導体
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN1869704B (zh) * 2006-06-14 2010-06-30 厦门大学 快速鉴定与病原菌互作的宿主蛋白的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710469A (en) * 1986-05-02 1987-12-01 Merck & Co., Inc. Novel phosphotyrosyl protein phosphatase
ATE140483T1 (de) * 1988-11-10 1996-08-15 Genetics Inst Natürlicher killerzellen-stimulationsfaktor
ATE209251T1 (de) 1990-05-16 2001-12-15 Genetics Inst Knochen- und knorpel-bildung hervorrufende proteine
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5518911A (en) * 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
JP3088681B2 (ja) * 1997-05-22 2000-09-18 宮城県 形質膜局在シアリダーゼ及びそれをコードするｄｎａ
US6383734B1 (en) * 1998-09-30 2002-05-07 Advanced Research And Technology Institute, Inc. Method to determine inhibition of PAK3 activation of Raf-1
JP2000166545A (ja) * 1998-12-07 2000-06-20 Snow Brand Milk Prod Co Ltd 胆汁酸活性化リパーゼ
AU3566200A (en) 1999-04-01 2000-10-23 Astrazeneca Uk Limited Human signal transduction serine/threonine protein kinase
WO2000063703A1 (en) * 1999-04-16 2000-10-26 Schering Corporation Use of azetidinone compounds
DE10042447A1 (de) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports

Also Published As

Publication number Publication date
JP2006512054A (ja) 2006-04-13
US7786103B2 (en) 2010-08-31
CA2493487A1 (en) 2004-02-19
CA2493487C (en) 2013-01-22
NO20051169L (no) 2005-05-02
IL199409A (en) 2010-12-30
RU2345089C2 (ru) 2009-01-27
KR101095288B1 (ko) 2011-12-16
BR0313217A (pt) 2005-06-14
RU2005106238A (ru) 2005-08-27
WO2004014947A1 (en) 2004-02-19
EP1529061A1 (de) 2005-05-11
KR20060015443A (ko) 2006-02-17
NO333437B1 (no) 2013-06-03
US20040126812A1 (en) 2004-07-01
US20080167451A1 (en) 2008-07-10
CN1668642A (zh) 2005-09-14
IL166492A0 (en) 2006-01-15
AU2003253341C1 (en) 2009-09-24
US7435727B2 (en) 2008-10-14
CN1330667C (zh) 2007-08-08
AU2003253341B2 (en) 2009-04-23
EP1529061B1 (de) 2008-02-13
MXPA05001264A (es) 2005-04-28
DE60319093T2 (de) 2009-02-05
AU2003253341A1 (en) 2004-02-25
DE60319093D1 (de) 2008-03-27
JP4575772B2 (ja) 2010-11-04
HK1082509A1 (en) 2006-06-09
IL166492A (en) 2010-12-30
ZA200500053B (en) 2006-07-26
NO20130115L (no) 2005-05-02

Similar Documents

Publication Publication Date Title
DE60234464D1 (de) Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung
NO20051169L (no) Fremgangsmate for a isolere et intestinalt kolesterolbindende protein
DE602005015426D1 (de) System und Verfahren zur Intensivierung von Audiosignalen
DE602005004354D1 (de) Verfahren zur Lokalisierung von Fluoreszenzmarkers
DE60313283D1 (de) Verfahren zur zusammenfassung von unbekanntem videoinhalt
DE502005002767D1 (de) Abgasanlage sowie verfahren zum verbinden von komponenten einer abgasanlage
EP1546118A4 (de) Zusammensetzungen und verfahren zum nachweis und zur isolierung phosphorilierter molek le
ATE505453T1 (de) Verfahren zur hydrocyanierung von butadien
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE602006018035D1 (de) Verfahren und kit zur quantitativen bestimmung von small, dense ldl cholesterol
ATE408616T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
DE112004001806D2 (de) Verfahren zur Selbstjustierenden Verkleinerung von Strukturen
ATE336175T1 (de) Verfahren zur geruchsneutralisation von sojaprotein-zusatzstoffe
DE60336713D1 (de) Verfahren zur nassbehandlung von scheibenförmigen gegenständen
DE602004022042D1 (de) Verfahren und kit zur identifizierung antibiotikaresistenter mikroorganismen
ATE553543T1 (de) Verfahren und system zur bestimmung eines frequenzoffsets
AU2003258542A1 (en) Method for isolating atp binding proteins by means of immobolized protein inhibitors
TW200619875A (en) Compositions comprising tannic acid as corrosion inhibitor
ATE517858T1 (de) Verfahren zur aufreinigung von (meth)acrylaten
ATE539085T1 (de) Verfahren zur isolierung von haptoglobin
IL173506A0 (en) Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
DE50203864D1 (de) Verfahren zur Unterdrückung von Jammer-Signalen
DE10295540D2 (de) Verfahren zur Leckerkennung von Rohrleitungen
ATE415492T1 (de) Verfahren zum identifizieren von makrocyclischen polyketiden
ATE323155T1 (de) Verfahren zur extraktion von beta-amylase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties